Founded with a mission to revolutionize stroke treatment, MIVI Neuroscience is an innovative medical device company dedicated to improving outcomes for patients experiencing acute ischemic stroke (AIS). Leveraging proprietary technology developed in collaboration with physicians, MIVI aims to equip healthcare providers with advanced tools to enhance stroke care. Their product line includes the Q™ Aspiration Catheter and the Q™ Distal Access Catheter, designed to facilitate more effective and efficient stroke interventions.
MIVI Neuroscience has garnered attention from notable investors and industry leaders, contributing to its rapid growth and impact in the medical field. The company's achievements include significant advancements in stroke treatment technology and successful clinical outcomes, positioning it as a key player in the neurovascular market. Through its relentless pursuit of innovation, MIVI is expanding the possibilities in stroke treatment, ultimately aiming to save lives and improve patient recovery rates.
